Cerebral Stroke Clinical Trial
— AbotMotOfficial title:
Cortical and Biomechanical Dynamics of Ankle Robotics Training in Stroke
Verified date | December 2014 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
Reduced mobility and increased fall risk are significant long-term health problems facing
those who have persistent weakness or paralysis in their legs resulting from stroke. Recent
innovations in post-stroke therapy have applied motor learning principles to improve motor
skills through regular practice of activities using the weaker limb. Because the ankle is so
critical in providing forces for normal walking and balance function, impairments at the
affected ankle pose a major limitation to achieving optimal rehabilitation outcomes. To
address this we have developed a novel ankle robot (Anklebot) to enhance physical therapy
for improving walking and balance functions after stroke. It is a computer controlled
exercise machine that can be worn during walking or in a seated position for practice with
video games. The Anklebot controllers allow for assisting users when they cannot complete a
movement, or resisting movement, or simply recording movements and forces.
Passive movement therapy has shown promise in exciting brain to muscle connections for
recovery of walking function; however it does not appear to yield optimal results,
suggesting that active involvement in task-oriented therapy is essential. Not only is
voluntary movement important to initiate this excitation, the brain mechanisms of reward and
motivation play an important role. These mechanisms have been widely studied in both humans
and animals. Core brain networks involved in reward and motivation are designed to increase
a person's involvement with their surroundings, to focus attention and to prompt one to
approach reward and avoid punishers. These increases in involvement and the elevated
emotions that are part of it have been shown to enhance performance, memory and learning.
The primary purpose of this pilot study is to investigate responses of brain and muscle
activity in stroke patients who use the Anklebot during a 3-week / 3-session/week motor
learning based training. These responses will be compared to a 3-week delayed entry period
in which the participants will perform an at-home walking program equal in time spent to the
time they will spend on the Anklebot during the 3-week / 3x/week training. In Addition,
after the 3-week delayed entry walking program the subjects will be divided into low and
high reward-feedback groups. The low reward-feedback group will receive the Anklebot
training with only immediate feedback (they will know if they succeeded on the current trial
but they will never know their cumulative score and they will receive minimal social
interaction with research team members. While the high-reward feedback group will know their
cumulative scores, will receive controlled but abundant social interaction with the research
team and will be eligible for prizes of restaurant and movie coupons during individual
training sessions and at completion of the study. This will be done to assess the ability of
higher reward conditions to increase recovery beyond that of the Anklebot training alone.
To accomplish this subjects with chronic stroke will be divided into the high and
low-reward/feedback groups and will then play a series of videogames using the Anklebot, as
we noninvasively record brain activity using electroencephalography (EEG) and muscle
activity using electromyography (EMG). We will also monitor heart rate using
electrocardiograms (ECG). In addition to analyzing brain and muscle information before,
during, and after the Anklebot training, we will also assess walking and balance functions
immediately before and after the first and last robotic training session and ask the
subjects to fill out some standardized questionnaires.
Status | Completed |
Enrollment | 40 |
Est. completion date | September 2014 |
Est. primary completion date | February 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Ischemic or hemorrhagic stroke greater than 3 months prior - Residual hemiparetic gait with observable asymmetry in the gait pattern. - Women or men aged 21 to 85 years - Completed all conventional physical therapy. - Adequate language and neurocognitive function to participate in training, testing, and to give informed consent. - Minimal ankle flexion in either direction (dorsi- or plantar-) Exclusion Criteria: - MMSE score < 23 (9th grade education or more) or MMSE score < 17 (8th grade education or less) - CES-D score > 16 - Clinical history of orthopedic, chronic pain or severe neuromuscular disorders restricting participation in a short term ankle movement training paradigm. - Severe or global receptive aphasia which confounds reliable testing and training. - Women of child-bearing potential, if there is any self-reported chance that they may be pregnant. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD | Baltimore | Maryland |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development | University of Maryland, Baltimore County |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Motor Control | Two Years | No | |
Secondary | Functional Walking and Balance Measures | Two Years | No | |
Secondary | EEG Spectral Estimates | Two Years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05591183 -
CERENOVUS Neurothrombectomy Devices Registry
|
||
Recruiting |
NCT03685578 -
CERENOVUS Neurothrombectomy Devices Registry
|
||
Completed |
NCT04465019 -
Exoskeleton Rehabilitation on TBI
|
||
Completed |
NCT02827825 -
Patients Undergoing Strokes Admitted in Intensive Care Requiring Neurosurgical ICU Crossing: Patient Profile and Prognosis
|
||
Recruiting |
NCT02077582 -
Longitudinal MRI Examinations of Patients With Brain Ischemia and Blood Brain Barrier Permeability
|
N/A | |
Completed |
NCT01732679 -
Sunnaas International Network´s Stroke Study
|
N/A | |
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT00311025 -
Stroke: Reduction of Physical Performance Post Stroke. Inactivity or Secondary Complications?
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03804125 -
A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
|
||
Completed |
NCT05435404 -
Qualitative Study Patient & Physician Experiences Botox COVID-19
|
||
Completed |
NCT03898960 -
Post Marketing Study to Evaluate the NIMBUS Device
|
||
Not yet recruiting |
NCT06087094 -
A Trial of HRS-7450 in Chinese Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02207023 -
Healthy Lifestyles After Stroke - Stroke Coach
|
N/A | |
Active, not recruiting |
NCT02017574 -
Motor Learning in Stroke
|
Phase 0 | |
Completed |
NCT02002390 -
Efficacy and Safety of FTY720 for Acute Stroke
|
Phase 2 | |
Completed |
NCT01864382 -
"Core Stability" Exercises to Improve Sitting Balance in Stroke Patients
|
N/A | |
Recruiting |
NCT04447599 -
Conjunctival and Retinal Vascularization and Small Vessel Disease
|
N/A | |
Recruiting |
NCT04157179 -
Cerebral Oxygen Metabolism in Children
|
N/A |